(Q43997715)

English

Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia

scientific article

Statements

Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia (English)
Myrna Candelaria
Omar López-Navarro
Aurora Gonzalez-Fierro
Lucia Taja-Chayeb
Daniela Gordillo-Bastidas
Alfonso Dueñas-González

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit